SANTA MONICA, Calif., Aug. 31, 2020 (GLOBE NEWSWIRE) — Opiant Pharmaceuticals, Inc. (“Opiant”) (NASDAQ: OPNT), a specialty pharmaceutical company developing medicines for addictions and drug overdose, announced today that its Chief Executive Officer, Dr. Roger Crystal, is scheduled to participate in a fireside chat to discuss its pipeline of products for addiction and overdose at the Cantor Global Virtual Healthcare Conference on Tuesday September 15th, 2020, at 2:40 pm EDT.
News Ticker
- [ November 30, 2023 ] Key Account Director (CA Region) – Kite Pharma – Anaheim, CA Los Angeles Biotech Jobs
- [ November 30, 2023 ] Director, National Accounts Payer – Kite Pharma – Los Angeles, CA Los Angeles Biotech Jobs
- [ November 30, 2023 ] Drug prices in TV ads again? Senators take another swing with expedited bill Los Angeles Biotech News
- [ November 30, 2023 ] IEHP-sponsored art contest adds colorful display to Coachella Valley bus line Los Angeles Biotech News
- [ November 30, 2023 ] Manufacturing Technician Pharmaceutical / Biotech / FDA Full Time $22+ – Grifols – Los Angeles, CA Los Angeles Biotech Jobs
Copyright © 2023 Biotech Networks, LLC
